Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Operating Expenses (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Operating Expenses for 6 consecutive years, with $32.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 13.11% year-over-year to $32.8 million, compared with a TTM value of $124.4 million through Dec 2025, up 13.83%, and an annual FY2025 reading of $124.4 million, up 13.83% over the prior year.
  • Operating Expenses was $32.8 million for Q4 2025 at Viemed Healthcare, roughly flat from $32.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $32.8 million in Q4 2025 and bottomed at $7.5 million in Q4 2021.
  • Average Operating Expenses over 5 years is $22.3 million, with a median of $24.9 million recorded in 2022.
  • The sharpest move saw Operating Expenses crashed 51.56% in 2021, then soared 221.04% in 2023.
  • Year by year, Operating Expenses stood at $7.5 million in 2021, then grew by 1.84% to $7.6 million in 2022, then skyrocketed by 221.04% to $24.6 million in 2023, then grew by 18.15% to $29.0 million in 2024, then increased by 13.11% to $32.8 million in 2025.
  • Business Quant data shows Operating Expenses for VMD at $32.8 million in Q4 2025, $32.7 million in Q3 2025, and $29.6 million in Q2 2025.